Patients On Chemotherapy Who Have Heart Disease: Barry Ramo

Transcription

Patients On Chemotherapy Who Have Heart Disease: Barry Ramo
4/9/2015
Cardio-Oncology for the Primary
Care Provider
as a result of the treatment.
Barry W. Ramo, MD,FACC
New Mexico Heart Institute
April 11, 2015
what is the least likely cause of
death for a patient who has
survived one cancer?
1. Cancer
2. Heart Disease
what is the most likely cause of
death for a patient who has
survived cancer?
1. Cancer
2. Heart Disease
Cancer patients are cured of
one life-threatening disease,
only to succumb to another —
heart failure —
1
4/9/2015
Cardiac Care of Patients with
Cancer
CV Evaluation, Risk Factors
Survival
Cancer
Diagnosis.
Cytotoxic Rx
Targeted XRT
Cardiac Care
• Cardiac
• CV
Toxicity
disease
• Strain
• Premature
,EF,Biomar
death
ker
• MRI
Primary Care Provider Role in Caring
for their Patients with Cancer
 Diagnosis
 During Therapy
 Post Therapy
Therapeutic and Cardiotoxic
Agents
Type 1
Anthrcyclines
Type 2
Herceptin
TARGETED THERAPY
• Tyrosine Kinase inhibitors
• VEGF Inhibitors
2
4/9/2015
Conflicting Goals
Maximize
therapeurtic
benefit
Kill the Prevent cancer
Cancer therapeutics
related cardiac
dysfunction
(CTRCD)
Detection of Early Toxicity
• Biomarkers: BNP, Troponin
• Left ventricular dysfunction
• Cardiac MR
Detection of Risk for Deterioration of Cardiac
Function after anthracyclines and Herceptin
• Predictors at 3 months
HS Troponin
Myocardial strain
• Not Predictive
• BNP
• Ejection Fraction
3
4/9/2015
Prevention of Cardiotoxicty
• Limited Data
• Beta Blocker, ACE-I combination in small
studies reduced LV dsyfunction Iib
recommendation
OVERDRIVE: EnalapriI + Carvedilol
With intensive Chemotherapy .
N=90
Mortality
6%
Mortality
22%
6.2%
33%
Cardiac Care of Patients with
Cancer
CV Evaluation, Risk Factors
Cardiac Care
Survival
Cancer
Diagnosis.
Cytotoxic Rx
Targeted XRT
•
•
•
Cardiac
Toxicity
Strain
,EF,Bioma
rker
MRI
• Late heart
failure
• HBP
• Optimize Risk
Factors
4
4/9/2015
Thank You
5

Similar documents

US Cardiac Rhythm Management Devices Market - Upcoming Opportunities and New Trends

US Cardiac Rhythm Management Devices Market - Upcoming Opportunities and New Trends The latest report, “United States Cardiac Rhythm Management Devices Market Outlook to 2021”, provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

More information